SK3 Group's Wholesale Managed Collective Portfolio Announces New Distributor in San Francisco Bay Area Expanding Company Prod...
24 März 2014 - 2:30PM
Marketwired
SK3 Group's Wholesale Managed Collective Portfolio Announces New
Distributor in San Francisco Bay Area Expanding Company Product
Reach
LOS ANGELES, CA--(Marketwired - Mar 24, 2014) - SK3 Group's (OTC
Pink: SKTO) (PINKSHEETS: SKTO) Medical Greens subsidiary is pleased
to announce that it now has an additional new distributor in the
San Francisco Bay Area in California for its wholesale managed
collective portfolio. This step increases the reach of its
wholesale managed collective portfolio into additional medical
cannabis dispensaries and delivery services for its various product
lines including: Dharmanol, Canna-Loz Organic Oil, T-Hydro-Can, Yak
Capsules, Yeti Honeybud Oilers, Organakoil, Greenie Whole Plant
Cookies, Haute Chocolate Instant Drink Mix, and Mocha-juana Instant
Drink Mix. This also opens the way for additional expansion of
the Pharmajanes.com delivery service.
The total population of the San Francisco Bay Area is over 7.1
million people, making it the second most populous urban area in
California after the Greater Los Angeles area, and the fifth
largest in the United States.
The Bay Area is where some of the most regulated and politically
supportive cities for medical marijuana in California are located,
such as San Francisco, Berkeley, and Oakland.
"This is another important addition to our distribution network
for our licensed products," said Artemus Mayor, President of SK3
Group. "San Francisco was home to the first public medical cannabis
dispensary in the United States, which paved the way for expansion
of medical marijuana to where we are today. We are continuing to
broaden our distribution network into key markets to facilitate
getting medicine to more patients who need our licensed medical
cannabis products as we build our brand."
About SKTO SK3 is a healthcare logistics and fulfillment
consultancy focused on the delivery of alternative care and
medicine. With seasoned management, breakthrough technology and
best practices, SK3 brings standardization and transparency to this
rapidly growing segment of the alternative care field.
FDA Statement The statements in this document have not been
evaluated or approved by the FDA. The products and statements
referenced in this document are not intended to diagnose, treat,
cure, or prevent any disease.
Safe Harbor Statement This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. These forward-looking statements are based on the
current plans and expectations of management and are subject to a
number of uncertainties and risks that could significantly affect
the company's current plans and expectations, as well as future
results of operations and financial condition. A more extensive
listing of risks and factors that may affect the company's business
prospects and cause actual results to differ materially from those
described in the forward-looking statements can be found in the
reports and other documents filed by the company with the
Securities and Exchange Commission. The company undertakes no
obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
Investor Relations SK3 Group, Inc. d.b. a Medical Greens
investors@medicalgreens.com
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
Von Jun 2023 bis Jun 2024